ReferenceID 3455
Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
Cancers (Basel)
Prostate cancer (PrCa) metastasis is the major cause of mortality and morbidity among men. Metastatic PrCa cells are typically adopted for aberrant glucose metabolism. Thus, chemophores that reprogram altered glucose met
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 3455
- Evidence Id
- 20045
- Core Evidence Id
- 20045
- Source Reference Id
- 238
- Herb2 Reference Id
- HBREF000448
- Subject Paper Key
- HBIN021848_30875788
- Pubmed Id
- 30875788
- Doi
- 10.3390/cancers11030364
- Paper Title
- Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
- Paper Abstract
- Prostate cancer (PrCa) metastasis is the major cause of mortality and morbidity among men. Metastatic PrCa cells are typically adopted for aberrant glucose metabolism. Thus, chemophores that reprogram altered glucose metabolic machinery in cancer cells can be useful agent for the repression of PrCa metastasis. Herein, we report that cucurbitacin D (Cuc D) effectively inhibits glucose uptake and lactate production in metastatic PrCa cells via modulating glucose metabolism. This metabolic shift by Cuc D was correlated with decreased expression of GLUT1 by its direct binding as suggested by its proficient molecular docking (binding energy -8.5 kcal/mol). Cuc D treatment also altered the expression of key oncogenic proteins and miR-132 that are known to be involved in glucose metabolism. Cuc D (0.1 to 1 M) treatment inhibited tumorigenic and metastatic potential of human PrCa cells via inducing apoptosis and cell cycle arrest in G2/M phase. Cuc D treatment also showed inhibition of tumor growth in PrCa xenograft mouse model with concomitant decrease in the expression of GLUT1, PCNA and restoration of miR-132. These results suggest that Cuc D is a novel modulator of glucose metabolism and could be a promising therapeutic modality for the attenuation of PrCa metastasis.
- Journal
- Cancers (Basel)
- Publish Year
- 2019
- Experiment Subject
- human prca cells
- Experiment Type
- Cell Experiment
- Phenotype Related
- Prostate Cancer
- Paper Title Cn
- Paper Title En
- Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
- Bilingual Status
- semi_complete